Searching News Database: MorphoSys AG
HSMN NewsFeed - 28 Sep 2021
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed - 3 Nov 2008
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Additional items found! 6
Members Archive contains
6 additional stories matching:
MorphoSys AG
(Password required)
MorphoSys AG
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!